Neuropsychotropic Drug Therapy 2021 | New Medications in Movement Disorders

Neuropsychotropic Drug Therapy 2021

New Medications in Movement Disorders

On-Demand Program

Speaker

Shu-Ching Hu, MD, PhD
Movement Disorder Neurologist, Associate Professor of Neurology, University of Washington, Seattle

Target Audience

Objectives for Learning Outcomes

At the conclusion of this activity, participants will be better able to:

1. Gain knowledge on the updates of Tardive Dyskinesia and its treatment.
2. Describe new medications for Parkinson’s Disease.
3. Describe new medications for non-motor symptoms of Parkinson’s Disease.